ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,349Medicare Part D Prescriptions Filled, Including Refills

Rank: 139 out of 2604

$532K Total Retail Price of All Prescriptions

Rank: 173 out of 2604

323 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 323 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 323 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 5,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 408 106 S3 1 1
OMEPRAZOLE 364 245 2 5
SIMVASTATIN 319 189 3 2
FUROSEMIDE 272 234 4 8
LEVOTHYROXINE SODIUM 268 187 5 4
HYDROCHLOROTHIAZIDE 242 161 6 10
GABAPENTIN 210 113 7 12
ENALAPRIL MALEATE 174 102 8 50
METOPROLOL TARTRATE 166 102 9 9
METFORMIN HCL 158 81 10 7
METOPROLOL SUCCINATE 153 115 11 17
LISINOPRIL 140 115 12 3
AMLODIPINE BESYLATE 130 104 13 6
LOVASTATIN 128 85 14 24
FENOFIBRATE 122 77 15 69
RANITIDINE HCL 117 36 16 25
ALENDRONATE SODIUM 117 98 16 29
PREDNISONE 106 63 18 34
POTASSIUM CHLORIDE 101 89 19 16
CLONIDINE HCL 100 69 20 56
SERTRALINE HCL 100 59 20 23
LYRICA 91 13 22 79
CIPROFLOXACIN HCL 85 62 23 59
MELOXICAM 85 43 23 36
CITALOPRAM HBR 79 38 25 18
TRAZODONE HCL 79 42 25 46
DIGOXIN 78 65 27 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 76 40 28 22
DONEPEZIL HCL 75 75 29 28
WARFARIN SODIUM 74 56 30 13
TAMSULOSIN HCL 73 49 31 30
MORPHINE SULFATE 70 31 S2 32 140
GEMFIBROZIL 69 35 33 87
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 37 34 91
QUETIAPINE FUMARATE 63 29 35 66
CYCLOBENZAPRINE HCL 61 0 R 36 43
ATENOLOL 61 45 36 11
CEPHALEXIN 59 41 38 74
PAROXETINE HCL 58 41 39 62
MORPHINE SULFATE ER 58 0 S2 39 58
CLOPIDOGREL 57 36 41 39
LANTUS 56 32 42 40
PROAIR HFA 56 23 42 27
ZOLPIDEM TARTRATE 55 18 44 21
OXYBUTYNIN CHLORIDE 54 45 45 92
BACLOFEN 54 13 45 101
CARVEDILOL 54 46 45 26
GLIPIZIDE 54 36 45 51
LOSARTAN POTASSIUM 52 30 49 20
TRAMADOL HCL 51 33 50 15
AMITRIPTYLINE HCL 51 12 R 50 82
INSULIN SYRINGE 51 22 50 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.